Current producing surface for a wound dressing

Information

  • Patent Grant
  • 7457667
  • Patent Number
    7,457,667
  • Date Filed
    Thursday, February 19, 2004
    20 years ago
  • Date Issued
    Tuesday, November 25, 2008
    15 years ago
Abstract
In an embodiment, an article includes a primary surface, and a pattern of spaced dissimilar materials, on the primary surface. The pattern is to spontaneously produce electrical surface currents when brought into contact with an electrically conducting solution.
Description
BACKGROUND OF THE INVENTION

Bandages and wound dressings are simple, familiar devices. In an effort to hasten the wound healing process or reduce the risk of infection, there have been many recent efforts to redesign, or sometimes redefine, a bandage. Few people have enjoyed the benefits of some new bandages, because they are either too complex or too expensive.


The major advances in the art of wound healing are usually either improved methods for reducing infection or stimulating cell repair. It is now known that a moist wound heals faster and is less likely to scar than a dry wound, so the use of traditional bandages to keep a wound moist and protected is correct. It is also known that silver is an anti-microbial agent, so there are numerous products that deliver silver to a wound, such as Smith & NephewSM ACTICOAT 7™, Johnson & Johnson® ACTISORB™, and Bristol-Meyers SquibbSM HYDROFIBER®.


Covering a wound is easy, and there are numerous products that fill that need. Delivering silver to a wound, however, has posed many difficulties because silver is a metal. Some methods resort to using silver crystals, which have a large relative surface area. Colloidal silver, silver salts (e.g. silver nitrate) and silver compounds (e.g. silver sulfadiazine) have been used to make creams and ointments. Creams and ointments are popular in the field of medicine because they are easy to use and familiar.


There are devices that rely on either an external electrical power source or a direct reaction between silver and another metal to generate the production of silver ions. One technology, described in U.S. Pat. Nos. 4,657,808 and 4,529,623 to Frederick Maggs consists of activated carbon with silver dispersed within it. Other technologies, described in U.S. Pat. Nos. 5,681,575, 5,753,251, 5,770,255, and 5,837,275 to Dr. Robert Burrell, et al., use vapor deposition techniques to apply a coating of silver onto a medical device. Yet another technology, described in U.S. Pat. No. 5,814,094 to Dr. Robert O. Becker, uses electricity (often from a coin battery) to produce free silver ions that may penetrate into the wound tissue. And yet another technology, described in U.S. Pat. No. 6,522,918 to Dr. William E. Crisp, et al., combines silver and another metal-bearing material within a thickness of material, such as a sponge. Unfortunately, these devices may require expensive manufacturing processes, and the devices themselves can be complex and cumbersome.


SUMMARY OF THE INVENTION

In an embodiment, an article includes a primary surface, and a pattern of spaced dissimilar materials, on the primary surface. The pattern is to spontaneously produce electrical surface currents when brought into contact with an electrically conducting solution.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a detailed plan view of a very basic embodiment of the present invention.



FIG. 2 is a detailed plan view of a pattern of printed electrical conductors in accordance with an embodiment of the present invention.



FIG. 3 is an adhesive bandage using the printed pattern of FIG. 2.



FIG. 4 is a cross-section of FIG. 3 through line 3-3.



FIG. 5 is a detailed plan view of an alternate embodiment of the present invention which includes fine lines of metal ink connecting electrodes.



FIG. 6 is a detailed plan view of another alternate embodiment of the present invention having a line pattern and dot pattern.



FIG. 7 is a detailed plan view of yet another alternate embodiment of the present invention having two line patterns.





The reference numbers used in the various Figs. are as follows:

    • 2 primary surface
    • 3 cross-section
    • 4 article
    • 6 first design
    • 8 spacing
    • 10 second design
    • 12 repetition
    • 14 pattern
    • 16 elastic adhesive layer
    • 18 overlapping piece
    • 20 back of the printed dressing material
    • 22 absorbent cloth layer
    • 24 fine lines


DETAILED DESCRIPTION OF THE INVENTION

The detailed description of embodiments of the present invention has been broken into two sections. The first section will teach how to make preferred and alternate embodiments. The second section explores theories that may explain why embodiments of the present invention achieve beneficial results, but it is not necessary to understand these theories in order to make, use or otherwise benefit from embodiments of the present invention. Any inaccuracies or oversimplifications of the theories presented in the second section should in no way detract from the scope of the claims, which focus on the embodiments and not the theories.


A preferred embodiment includes a bandage, more generally a wound dressing, but a method for making a wound dressing, in accordance with an embodiment of the present invention, can similarly be applied to virtually any medical device that contacts an electrolyte of the body, as will be apparent to one of skill in the art, based on the description herein. Actually, embodiments of the present invention can be applied to virtually any non-conductive surface that may come into contact with an electrolytic solution. A purpose of using the present invention is to reduce infection and contamination, but there are additional benefits specific to wound care that are of exceptional value. These benefits will be addressed in the second section.


Over 200 years ago, in 1800, Alessandro Volta assembled the first modern battery. He sandwiched a saltwater-soaked piece of paper between a zinc disc and a silver disc, and was electrically shocked by the potential difference, or voltage, that was created by his assembly. Volta's electrochemical cell generated an electrical current because of a spontaneous oxidation-reduction reaction. In his honor, this type of electrochemical cell is called a voltaic cell, but may also be referred to as a galvanic cell. In the case of silver and zinc, electrons are transferred from zinc metal to silver ions. The oxidation half reaction of zinc metal results in the loss of two electrons to produce zinc ion, and the reduction half reaction of silver ion results in the gain of one electron to produce silver metal. The zinc electrode is the anode (negative sign) and the silver electrode is the cathode (positive sign), because the electrons flow from zinc to silver. The flow of ions generates the electrical current, so the silver and zinc cannot directly contact each other or there will be a direct reaction with no current generated. An electrolyte, such as table salt, dissolves in water to provide an electrically conducting solution which electrically bridges the gap between the two dissimilar metals so that there is a current flow caused by the spontaneous reactions between the physically separated metals.


Dissimilar metals used to make the preferred embodiment of the present invention (a wound dressing) are silver and zinc, and the electrolytic solution includes sodium chloride in water. A unique aspect of some embodiments of the present invention is that the electrodes are painted or printed onto a non-conductive surface to create a pattern, most preferably an array, of voltaic cells that do not spontaneously react until they contact an electrolytic solution, such as wound fluid. The remainder of this description will use the terms “printing” with “ink”, but it is understood that the embodiments may instead be “painted” with “paints”. It is also assumed that a competent printer will know how to properly apply and cure the inks without any assistance, other than perhaps instructions that should be included with the selected binder that is used to make the ink mixtures that will be used in the printing process.


In FIG. 1, the electrodes are printed onto a desired primary surface 2 of an article 4 which, in the preferred embodiment, is that surface of a wound dressing that comes into direct contact with a wound. In alternate embodiments of the present invention, the primary surface is one which simply should be antimicrobial, such as a medical instrument, implant, surgical gown, gloves, socks, table, door knob, or other surface that will contact an electrolytic solution, including sweat, so that at least part of the pattern of voltaic cells will spontaneously react and kill bacteria or other microbes.


The printed electrodes adhere or bond to the primary surface 2 because a biocompatible binder is mixed, into separate mixtures, with each of the dissimilar metals that will create the pattern of voltaic cells, in an embodiments. Most inks are simply a binder mixed with pigment. Similarly, the metal inks are a binder mixed with a conductive element. The resulting metal ink mixtures may be used with an application method, such as screen printing, in an embodiment, to apply the electrodes to the primary surface in predetermined patterns. Once the inks dry and/or cure, the patterns of spaced electrodes will substantially maintain their relative position, even on a flexible material such as cloth. To make only a few of the wound dressings of an embodiment of the present invention, the mixtures can be hand painted onto a common adhesive bandage so that there is an array of alternating electrodes that are spaced about a millimeter apart on the primary surface of the bandage. The paint should be allowed to dry before being applied to a wound so that the zinc ink does not mix with the silver ink, which would destroy the array and cause direct reactions that will release the elements, but fail to simulate the current of injury, as will be explained later.


The binder may include any biocompatible liquid material that can be mixed with a conductive element (preferably metallic crystals of silver or zinc) to create an ink which may be applied as a thin coating to a surface. One suitable binder is a solvent reducible polymer, such as the polyacrylic non-toxic silk-screen ink manufactured by Colorcon, Inc., a division of Berwind Pharmaceutical Services, Inc. (see Colorcon's No-Tox®product line, part number NT28). The binder is mixed with high purity (at least 99.999%, in an embodiment metallic silver crystals to make the silver ink, in an embodiment. The silver crystals, which are made by grinding silver into a powder, are preferably smaller than 100 microns in size, or about as fine as flour. In an embodiment, the size of the crystals is about 325 mesh, which is typically about 40 microns in size, or a little smaller. The binder is separately mixed with high purity (at least 99.99%, in an embodiment) metallic zinc powder, in an embodiment, which has also preferably been sifted through standard 325 mesh screen, to make the zinc ink. For better quality control and more consistent results, most of the crystals used should be larger than 325 mesh and smaller than 200 mesh. Other powders of metal can be used to make other metallic inks in the same way as just described, in other embodiments.


The ratio of metal to binder affects the release rate of the metal from the mixture. When Colorcon's polyacrylic ink is used as the binder, about 10 to 40 percent of the mixture should be metal for a longer term bandage (one that stays on for about 10 days). If the same binder is used, but the percentage of the mixture that is metal is increased to 60 percent or higher, then the release rate will be much faster and a typical bandage will only be effective for a few days. It should be noted that polyacrylic ink tends to crack if applied as a very thin coat, which exposes more metal crystals which will spontaneously react. For alternate uses, such as on an article of clothing, it may be desired to decrease the percentage of metal down to 5 percent or less, or to use a binder that causes the crystals to be more deeply embedded, so that the primary surface will be antimicrobial for a very long period of time and will not wear prematurely. Other binders may dissolve or otherwise break down faster or slower than a polyacrylic ink, so adjustments should be made to achieve the desired rate of spontaneous reactions from the voltaic cells.


In various embodiments, when a single mass of silver ink is spaced from a single mass of zinc ink, a single voltaic cell is created when an electrolytic solution electrically connects the masses. If a single mass of silver ink is spaced from two masses of zinc ink, then two voltaic cells are created, and so on. To maximize the number of voltaic cells, in various embodiments, a pattern of alternating silver ink masses and zinc ink masses may create an array of electrical currents across the primary surface. A very basic pattern, shown in FIG. 1, has each mass of silver ink equally spaced from four masses of zinc ink, and has each mass of zinc ink equally spaced from four masses of silver ink, according to an embodiment. The first design 6 is separated from the second design 10 by a spacing 8. The designs, which are simply round dots, in an embodiment, are repeated. Numerous repetitions 12 of the designs result in a pattern. For a wound dressing, each silver ink design preferably has about twice as much mass as each zinc ink design, in an embodiment. For the pattern in FIG. 1, the silver ink designs are most preferably about a millimeter from each of the closest four zinc ink designs, and visa-versa. The resulting pattern of dissimilar metal masses defines an array of voltaic cells when introduced to an electrolytic solution.


A dot pattern of ink masses, like the alternating round dots of FIG. 1, is preferred when printing onto a flexible material, such as those used for a wound dressing, because the dots won't significantly affect the flexibility of the material. The pattern of FIG. 1 is well suited for general use. To maximize the density of electrical current over a primary surface, the pattern of FIG. 2 is preferred. The first design 6 in FIG. 2 is a large hexagonally shaped dot, and the second design 10 is a pair of smaller hexagonally shaped dots that are spaced from each other. The spacing 8 that is between the first design and the second design maintains a relatively consistent distance between adjacent sides of the designs. Numerous repetitions 12 of the designs result in a pattern 14 that can be described as at least one of the first design being surrounded by six hexagonally shaped dots of the second design. The pattern of FIG. 2 is well suited for abrasions and burns. There are, of course, other patterns that could be printed to achieve substantially the same results.



FIGS. 3 and 4 show how the pattern of FIG. 2 could be used to make an adhesive bandage. The pattern shown in detail in FIG. 2 is printed onto the primary surface 2 of a wound dressing material. The back 20 of the printed dressing material is fixed to an absorbent cloth layer 22, such as cotton. The absorbent cloth layer is adhesively fixed to an elastic adhesive layer 16 such that there is at least one overlapping piece 18 of the elastic adhesive layer that may be used to secure the wound dressing over a wound.



FIG. 5 shows an additional feature, which may be added between designs, that will start the flow of current in a poor electrolytic solution. A fine line 24 is printed, using one of the metal inks, along a current path of each voltaic cell. The fine line will initially have a direct reaction, but will be depleted until the distance between the electrodes increases to where maximum voltage is realized. The initial current produced is intended to help control edema so that the wound dressing will be effective. If the electrolytic solution is highly conductive when the wound dressing is initially applied, the fine line will be quickly depleted and the wound dressing will function as though the fine line had never existed.



FIGS. 6 and 7 show alternative patterns that use at least one line design. The first design 6 of FIG. 6 is a round dot, similar to the first design used in FIG. 1. The second design 10 of FIG. 6 is a line. When the designs are repeated, they define a pattern of parallel lines that are separated by numerous spaced dots. FIG. 7 uses only line designs. The pattern of FIG. 7 is well suited for cuts, especially when the lines are perpendicular to a cut. The first design 6 may be thicker or wider than the second design 10 if the oxidation-reduction reaction requires more metal from the first conductive element (mixed into the first design's ink) than the second conductive element (mixed into the second design's ink). The lines could be dashed. Another pattern could be silver ink grid lines that have zinc ink masses in the center of each of the cells of the grid. The pattern could even be letters printed from alternating inks so that a message can be printed onto the primary surface-perhaps a brand name.


There are numerous possible creative choices of patterns, but some patterns will work better with certain combinations of inks. Because the spontaneous oxidation-reduction reaction of silver and zinc uses approximately two silver and one zinc, the silver ink design may contain about twice as much mass as the zinc ink design, in an embodiment. At a spacing of about 1 mm between the closest dissimilar metals (closest edge to closest edge), each voltaic cell that is in wound fluid may create approximately 1 volt of potential that will penetrate substantially through the dermis and epidermis. Closer spacing of the dots may decrease the resistance, provide less potential, and the current will not penetrate as deeply. If the spacing falls below about one tenth of a millimeter, a realized benefit of the spontaneous reaction is that which is also present with a direct reaction—silver is electrically driven into the wound, but the current of injury may not be substantially simulated.


The remainder of this description is the second section, which focuses on the basic theories underlying why the present invention promotes wound healing. The introduction of silver metal onto a wound surface and/or into the region of damaged tissue promotes healing by direct suppression of local micro-organisms normally colonizing the wound. Bacterial pathogens commonly include gram-positive cocci such as Staphylococcus aureus and group A streptococci and gram-negative bacilli such as Pseudomonas aeruginosa, Escherichia coli, and Proteus spp. The electrochemical nature of silver is such that it is positively charged and thus is able to bind to negatively charged sulfur moieties of the amino acids methionine and cysteine composing critical structural and enzymatic proteins utilized by bacterial cells. The effect of this binding interaction between silver and bacterial proteins is that the proteins' intrinsic chemical bonds are disrupted, causing the bacterial proteins to denature, or change 3-dimensional conformation, and thereby to be functionally ineffective in a way that is of mortal consequence to the bacterial cell.


It has proven to be beneficial to drive silver into the wound. In addition, in accordance with embodiments of the present invention, because the induced electrical current has been shown to electrochemically attract microbes to the surface of the bandage, many of the killed microbes are removed with the bandage instead of accumulating within the wound and necessitating the phagocytic engulfment and removal by macrophages in the natural but slower process of wound healing. Of additional concern in not removing dead bacterial cells from the wound vicinity is the release of toxic enzymes and chemicals from the dead and degrading bacteria, thought to be alleviated by application of embodiments of the present invention. Bacteria and other microbes are specifically drawn to the cathode (silver in the preferred embodiment) by virtue of their overall net negative charge along the created electric gradient. Because all microbes are net negatively charged, they die when they contact silver.


The most preferred material to use in combination with silver to create the voltaic cells of embodiments of the present invention is zinc. Zinc has been well-described for its uses in prevention of infection in such topical antibacterial agents as Bacitracin zinc, a zinc salt of Bacitracin. Zinc is a divalent cation with antibacterial properties of its own in addition to possessing the added benefit of being a cofactor to proteins of the metalloproteinase family of enzymes important to the phagocytic debridement and remodeling phases of wound healing. As a cofactor, zinc promotes and accelerates the functional activity of these enzymes, resulting in better, more efficient wound healing.


In a wound, the absence of the positively charged epithelium-negatively charged dermis combination which is normally observed in healthy tissue results in a deficit in the naturally occurring potential difference across the body surface. The silver-zinc voltaic cells of the preferred embodiment of the present invention recreates the physiologic current of injury important to the induction of neutrophil, macrophage and fibroblast cells essential to the healing process. In addition, the simulated current of injury stimulates regional nerve endings to promote their involvement in wound resolution.


The voltage present at the sight of a wound has been traditionally in the range of millivolts, but embodiments of the present invention may introduce a much higher voltage, near 1 volt when using the 1 mm spacing of dissimilar metals already described. The higher voltage is believed to drive the current deeper into the wound bed so that dermis and epidermis benefit from the simulated current of injury. In this way, the current not only drives some silver and zinc into the wound to kill microbes, but the current also provides the stimulatory current of injury so that the entire wound surface area can heal simultaneously, in an embodiment. Without the wound dressing of embodiments of the present invention, the current of injury may only naturally exist at the periphery of the wound that is within about half a millimeter of undamaged skin. That is why a wound closes from the edges in. A benefit of covering the entire wound with a simulated current of injury, in accordance with various embodiments, is that the volume of skin being repaired at the same time may be significantly increased.


A further benefit of a current producing wound dressing addresses the medically known fact that a wound closes faster if it is kept moist and clean. Edema should be minimized without allowing the wound surface to desiccate. The moisture balance of a wound should allow the damaged area to remain electrically conductive so that there are not areas of high resistance that block conduction of the simulated current of injury from penetrating into the tissue. Any excessive moisture and swelling creates an ideal environment for the growth of bacteria and microbes. Excess moisture that causes the damaged tissue to swell is best drawn out of the wound by being absorbed into cotton or another absorbent cloth material that will wick the excess moisture off the top of the wound surface without promoting any drying of the damaged tissue.


Finally, it is preferable to control the release rate of the dissimilar metals of the current producing wound dressing of various embodiments for two reasons, each in opposition to the other. In the preferred embodiment, the voltaic cells of the wound dressing drive the simulated current of injury deeper into the wound area if the dissimilar metals are kept separated by a predetermined distance, such that it would be undesirable to allow the silver to freely mix into the wound fluids as this would quickly result in a quenching of the electrochemical gradient and thus an extinguishing of the desired voltaic effect. On the other hand, if a predetermined quantity of silver is allowed to mix into the wound, the silver will help prevent wound infection. (Please note that the spontaneous reactions of the voltaic cells will release elements into the wound even though the most desired method of killing microbes is at the cathodes, as already described.)


Because it is desirable to have both the current of injury and the antimicrobial effects of silver present, a compromise may be made. To achieve a balance, the binder should release silver and zinc into the wound while simultaneously maintaining the simulated current of injury for the entire period of time that the bandage is intended to be left on the wound. Wound dressings that should be changed more often can have a shorter life as a current producing dressing, so the release rate of the binder can be faster. Wound dressings that are intended to be left on the wound for an extended period of time, say 10 days, should have a binder that does not dissolve or otherwise breakdown as quickly, or the percentage of binder to metallic crystals should be higher. This can be controlled by the intelligent selection of different mixture ratios and/or binder materials having longer or shorter half-lives or absorption rates, in various embodiments.


While various embodiments of the invention have been shown and described, it will be realized that alterations and modifications may be made thereto without departing from the scope of the following claims. For example, it may be desirable to use methods other than a common screen printing machine to print the electrodes of the present invention onto surfaces on medical instruments, garments, implants and the like so that they are antimicrobial. It is expected that other methods of applying the paint or ink may be substituted as appropriate. Also, there are numerous shapes, sizes and patterns of voltaic cells that have not been described, but it is expected that this teaching will enable those skilled in the art to incorporate their own designs which will then be painted or printed onto a surface to create voltaic cells which will become active when brought into contact with an electrolytic solution.

Claims
  • 1. A wound dressing comprising: a primary surface of a pliable dressing material, wherein the pliable dressing material is adapted to be applied to an area of damaged tissue;a first design formed from a first ink that includes a mixture of a polymer and a first element, the first ink being printed into a position of contact with the primary surface, the first element including a metal species, and the first design including at least one dot, wherein selective ones of the at least one dot have approximately a 1.5 mm+/− 1 mm mean diameter;a second design formed from a second ink that includes a mixture of a polymer and a second element, the second element including a different metal species than the first element, the second ink being printed into a position of contact with the primary surface, and the second design including at least one other dot, wherein selective ones of the at least one other dot have approximately a 2.5 mm+− 2 mm mean diameter;a spacing on the primary surface that is between the first design and the second design such that the first design does not physically contact the second design, wherein the spacing is approximately 1.5 mm+− 1 mm; andat least one repetition of the first design and the second design, the at least one repetition of the first design being substantially adjacent the second design, wherein the at least one repetition of the first design and the second design, in conjunction with the spacing between the first design and the second design, defines at least one pattern of at least one voltaic cell for spontaneously generating at least one electrical current when introduced to an electrolytic solution.
  • 2. A wound dressing comprising: a primary surface of a pliable dressing material, wherein the pliable dressing material is adapted to be applied to an area of damaged tissue;a first design formed from a first ink that includes a mixture of a polymer and a first element, the first ink being printed into a position of contact with the primary surface, the first element including a metal species, and the first design including at least one hexagonally shaped dot;a second design formed from a second ink that includes a mixture of a polymer and a second element, the second element including a different metal species than the first element, the second ink being printed into a position of contact with the primary surface, and the second design including at least one other dot, the at least one other dot including two hexagonally shaped dots that are spaced from each other;a spacing on the primary surface that is between the first design and the second design such that the first design does not physically contact the second design; andat least one repetition of the first design and the second design, the at least one repetition of the first design being substantially adjacent the second design wherein multiple repetitions of the first design and the second design result in at least one pattern characterized by the first design being surrounded by six hexagonally shaped dots of the second design, wherein the at least one pattern defines at least one voltaic cell for spontaneously generating at least one electrical current when introduced to an electrolytic solution.
  • 3. A method of making a wound dressing comprising: applying a first fluid to a face of a pliable dressing material to form a first design, wherein the first fluid includes a first biocompatible polymer and a first element;applying a second fluid to the face of the pliable dressing material to form a second design such that the second design is not physically contacting the first design, wherein the second fluid includes a second biocompatible polymer and a second element;repeating the first design and the second design to create a pattern that alternates between the first design and the second design;fixing an absorbent cloth layer to a back of the pliable dressing material, wherein the back of the pliable dressing material comprises a surface opposite the face of the pliable dressing material; andbonding an elastic adhesive layer to the absorbent cloth layer such that there is at least one overlapping piece of the elastic adhesive layer for securing the face of the pliable dressing material over an area of damaged tissue in a manner that allows the first and second elements of the corresponding first and second fluids to be introduced directly to the area of damaged tissue.
  • 4. The method of claim 3 wherein the first element includes a silver powder, and wherein the second element includes a zinc powder.
  • 5. The method of claim 4 wherein applying the first fluid and applying the second fluid include screen printing the first fluid and the second fluid onto the face of pliable dressing material.
  • 6. The method of claim 4 wherein at least some of the particles of the silver powder are approximately 100 microns or less in size.
  • 7. The method of claim 3 wherein: the first design includes at least one dot, and selective ones of the at least one dot have an approximately 1.5 mm± 1 mm mean diameter;a second design includes at least one other dot, and selective ones of the at least one other dot have an approximately 2.5 mm± 2 mm mean diameter; andforming a spacing on the pliable dressing material between the at least one dot of the first design and the at least one other dot of the second design such that the first design does not physically contact the second design, the spacing being approximately 1.5 mm± 1 mm.
US Referenced Citations (102)
Number Name Date Kind
116562 Collins Jul 1871 A
167162 French Aug 1875 A
175974 Hall Apr 1876 A
222276 Hunter Dec 1879 A
393741 Collins Dec 1888 A
3774592 Lahr Nov 1973 A
3848608 Leonard Nov 1974 A
4034750 Seiderman Jul 1977 A
4067342 Burton Jan 1978 A
4142521 Konikoff Mar 1979 A
4211222 Tapper Jul 1980 A
4528265 Becker Jul 1985 A
4529623 Maggs Jul 1985 A
4540604 Siuta Sep 1985 A
4569673 Tesi Feb 1986 A
4585652 Miller et al. Apr 1986 A
4657808 Maggs Apr 1987 A
4767401 Seiderman Aug 1988 A
4817594 Juhasz Apr 1989 A
4852571 Gadsby et al. Aug 1989 A
4937323 Silver et al. Jun 1990 A
5053001 Reiler et al. Oct 1991 A
5143079 Frei et al. Sep 1992 A
5288289 Haak et al. Feb 1994 A
5298017 Theeuwes et al. Mar 1994 A
5322520 Milder Jun 1994 A
5352315 Carrier et al. Oct 1994 A
5360440 Andersen Nov 1994 A
5405317 Myers et al. Apr 1995 A
5454886 Burrell et al. Oct 1995 A
5681575 Burrell et al. Oct 1997 A
5685837 Horstmann Nov 1997 A
5695857 Burrell et al. Dec 1997 A
5725817 Milder Mar 1998 A
5741224 Milder et al. Apr 1998 A
5753251 Burrell et al. May 1998 A
5759564 Milder et al. Jun 1998 A
5770255 Burrell et al. Jun 1998 A
5772688 Muroki Jun 1998 A
5782788 Widemire Jul 1998 A
5814094 Becker et al. Sep 1998 A
5837275 Burrell et al. Nov 1998 A
5944685 Muroki Aug 1999 A
5958440 Burrell et al. Sep 1999 A
5974344 Shoemaker, II Oct 1999 A
5985308 Burrell et al. Nov 1999 A
6017553 Burrell et al. Jan 2000 A
6038485 Axelgaard Mar 2000 A
6080490 Burrell et al. Jun 2000 A
6087549 Flick Jul 2000 A
6181963 Chin et al. Jan 2001 B1
6238686 Burrell et al. May 2001 B1
6248449 Watanabe Jun 2001 B1
6287484 Hausslein et al. Sep 2001 B1
6306419 Vachon Oct 2001 B1
6333093 Burrell et al. Dec 2001 B1
6365220 Burrell et al. Apr 2002 B1
6522918 Crisp et al. Feb 2003 B1
6582713 Newell et al. Jun 2003 B2
6631294 Andino et al. Oct 2003 B2
6723350 Burrell et al. Apr 2004 B2
6738662 Frank May 2004 B1
6788978 Vesnaver Sep 2004 B2
6861570 Flick Mar 2005 B1
20020004640 Conn et al. Jan 2002 A1
20020122787 Newell et al. Sep 2002 A1
20020161405 Druko Oct 2002 A1
20020182485 Anderson et al. Dec 2002 A1
20020188282 Greenberg Dec 2002 A1
20030074042 Gadsby et al. Apr 2003 A1
20030144723 Andino et al. Jul 2003 A1
20040015223 Andino et al. Jan 2004 A1
20040030276 Flick Feb 2004 A1
20040049145 Flick Mar 2004 A1
20040059282 Flock et al. Mar 2004 A1
20040162602 Cohen Aug 2004 A1
20040167461 Nitzan et al. Aug 2004 A1
20040193089 Fischer et al. Sep 2004 A1
20040199086 Crisp Oct 2004 A1
20040265395 Sun et al. Dec 2004 A1
20040267169 Sun et al. Dec 2004 A1
20040267231 Sun et al. Dec 2004 A1
20040267232 Sun et al. Dec 2004 A1
20040267237 Sun et al. Dec 2004 A1
20050004506 Gyory Jan 2005 A1
20050004508 Sun et al. Jan 2005 A1
20050004509 Sun et al. Jan 2005 A1
20050004550 Sun et al. Jan 2005 A1
20050010161 Sun et al. Jan 2005 A1
20050010192 Sun et al. Jan 2005 A1
20050015042 Sun et al. Jan 2005 A1
20050085751 Daskal et al. Apr 2005 A1
20050125006 Nady Jun 2005 A1
20050125009 Perry et al. Jun 2005 A1
20050125012 Houser et al. Jun 2005 A1
20050125016 Trerotola Jun 2005 A1
20050125018 Galloway et al. Jun 2005 A1
20050125021 Nance et al. Jun 2005 A1
20050148996 Sun et al. Jul 2005 A1
20050192636 Skiba et al. Sep 2005 A1
20060015052 Crisp Jan 2006 A1
20060015053 Crisp Jan 2006 A1
Foreign Referenced Citations (4)
Number Date Country
1588933 Apr 1981 GB
03-080874 Apr 1991 JP
WO-0112157 Feb 2001 WO
WO-2004022033 Mar 2004 WO
Related Publications (1)
Number Date Country
20050187580 A1 Aug 2005 US